{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:52:47Z","timestamp":1771980767049,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["Project UID\/Multi \/00709"],"award-info":[{"award-number":["Project UID\/Multi \/00709"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/115693\/2016"],"award-info":[{"award-number":["SFRH\/BD\/115693\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BDE\/112920\/2015"],"award-info":[{"award-number":["SFRH\/BDE\/112920\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010784","name":"Banco Santander","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010784","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12032-018-1100-0","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T15:55:28Z","timestamp":1519401328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens"],"prefix":"10.1007","volume":"35","author":[{"given":"In\u00eas Margarida","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Sandra Moreira","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Maria In\u00eas","family":"Alvelos","sequence":"additional","affiliation":[]},{"given":"Cec\u00edlia Reis","family":"Santos","sequence":"additional","affiliation":[]},{"given":"S\u00edlvia","family":"Socorro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5658-5445","authenticated-orcid":false,"given":"Cl\u00e1udio Jorge","family":"Maia","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"issue":"1","key":"1100_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1100_CR2","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/S0022-5347(01)62196-7","volume":"160","author":"AM Marzo de","year":"1998","unstructured":"de Marzo AM, et al. Stem cell features of benign and malignant prostate epithelial cells. J Urol. 1998;160(6):2381\u201392.","journal-title":"J Urol"},{"key":"1100_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-243-4_2","volume-title":"Androgen action","author":"D Wang","year":"2011","unstructured":"Wang D, Tindall DJ. Androgen action during prostate carcinogenesis. In: Saatcioglu F, editor. Androgen action. Berlin: Springer; 2011. p. 25\u201344."},{"issue":"1","key":"1100_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1158\/1541-7786.MCR-11-0524","volume":"10","author":"TG Grunewald","year":"2012","unstructured":"Grunewald TG, et al. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors. Mol Cancer Res. 2012;10(1):52\u201365.","journal-title":"Mol Cancer Res"},{"issue":"25","key":"1100_CR5","doi-asserted-by":"publisher","first-page":"14523","DOI":"10.1073\/pnas.96.25.14523","volume":"96","author":"RS Hubert","year":"1999","unstructured":"Hubert RS, et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. PNAS. 1999;96(25):14523\u20138.","journal-title":"PNAS"},{"issue":"1\u20133","key":"1100_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12020-008-9113-7","volume":"34","author":"CJB Maia","year":"2008","unstructured":"Maia CJB, et al. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland. Endocrine. 2008;34(1\u20133):108\u201316.","journal-title":"Endocrine"},{"issue":"15","key":"1100_CR7","first-page":"5857","volume":"61","author":"D Yang","year":"2001","unstructured":"Yang D, et al. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res. 2001;61(15):5857\u201360.","journal-title":"Cancer Res"},{"issue":"6","key":"1100_CR8","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/pros.22601","volume":"73","author":"IM Gomes","year":"2012","unstructured":"Gomes IM, et al. Six transmembrane epithelial antigen of the prostate 1 is down-regulated by sex hormones in prostate cells. Prostate. 2012;73(6):605\u201313.","journal-title":"Prostate"},{"issue":"1","key":"1100_CR9","doi-asserted-by":"publisher","first-page":"53.e23","DOI":"10.1016\/j.urolonc.2013.08.028","volume":"32","author":"IM Gomes","year":"2013","unstructured":"Gomes IM, Arinto P, Lopes C, Santos CR, Maia CJ. STEAP1 is over-expressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score. Urol Oncol Semin Orig Investig. 2013;32(1):53.e23\u20139.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"3","key":"1100_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1568009617666170427103732","volume":"18","author":"J Barroca-Ferreira","year":"2018","unstructured":"Barroca-Ferreira J, et al. Targeting STEAP1 protein in human cancer: current trends and future challenges. Curr Cancer Drug Targets. 2018;18(3):222\u201330. https:\/\/doi.org\/10.2174\/1568009617666170427103732 .","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"1100_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00262-006-0165-3","volume":"55","author":"PMS Alves","year":"2006","unstructured":"Alves PMS, et al. STEAP, a prostate tumor antigen, is a target of human CD8+ T cells. Cancer Immunol Immun. 2006;55(12):1515\u201323.","journal-title":"Cancer Immunol Immun"},{"issue":"5","key":"1100_CR12","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.juro.2009.12.094","volume":"183","author":"M Azumi","year":"2010","unstructured":"Azumi M, et al. Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer. J Urol. 2010;183(5):2036\u201344.","journal-title":"J Urol"},{"issue":"3","key":"1100_CR13","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/0008-5472.CAN-06-2996","volume":"67","author":"MDLL Garcia-Hernandez","year":"2007","unstructured":"Garcia-Hernandez MDLL, et al. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer Res. 2007;67(3):1344\u201351.","journal-title":"Cancer Res"},{"issue":"8","key":"1100_CR14","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/annonc\/mdr605","volume":"23","author":"T Grunewald","year":"2012","unstructured":"Grunewald T, et al. High STEAP1 expression is associated with improved outcome of Ewing\u2019s sarcoma patients. Ann Oncol. 2012;23(8):2185\u201390.","journal-title":"Ann Oncol"},{"issue":"1","key":"1100_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.canlet.2008.07.037","volume":"273","author":"MT Valenti","year":"2009","unstructured":"Valenti MT, et al. STEAP mRNA detection in serum of patients with solid tumours. Cancer Lett. 2009;273(1):122\u20136.","journal-title":"Cancer Lett"},{"issue":"5","key":"1100_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1158\/1541-7786.MCR-11-0281","volume":"10","author":"IM Gomes","year":"2012","unstructured":"Gomes IM, Maia CJ, Santos CR. STEAP proteins: from structure to applications in cancer therapy. Mol Cancer Res. 2012;10(5):573\u201387.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"1100_CR17","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1158\/0008-5472.CAN-06-3849","volume":"67","author":"PM Challita-Eid","year":"2007","unstructured":"Challita-Eid PM, et al. Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo. Cancer Res. 2007;67(12):5798\u2013805.","journal-title":"Cancer Res"},{"issue":"17","key":"1100_CR18","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.yexcr.2013.07.025","volume":"319","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T, et al. Six-transmembrane epithelial antigen of the prostate-1 plays a role for in vivo tumor growth via intercellular communication. Exp Cell Res. 2013;319(17):2617\u201326.","journal-title":"Exp Cell Res"},{"issue":"4","key":"1100_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/BF03345787","volume":"33","author":"M Valenti","year":"2010","unstructured":"Valenti M, et al. Zoledronic acid decreases mRNA six-transmembrane epithelial antigen of prostate protein expression in prostate cancer cells. J Endocrinol Invest. 2010;33(4):244\u20139.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"1100_CR20","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1100_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.","journal-title":"Cell"},{"issue":"4","key":"1100_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642\u201355.","journal-title":"Cell"},{"issue":"3\u20134","key":"1100_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.18632\/genesandcancer.13","volume":"5","author":"IM Gomes","year":"2014","unstructured":"Gomes IM, Santos CR, Maia CJ. Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms. Genes Cancer. 2014;5(3\u20134):142\u201351.","journal-title":"Genes Cancer"},{"issue":"18","key":"1100_CR24","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/sj.onc.1208474","volume":"24","author":"G He","year":"2005","unstructured":"He G, et al. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene. 2005;24(18):2929\u201343.","journal-title":"Oncogene"},{"key":"1100_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0300-483X(02)00460-2","volume":"181\u2013182","author":"JA Pietenpol","year":"2002","unstructured":"Pietenpol JA, Stewart ZA. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology. 2002;181\u2013182:475\u201381.","journal-title":"Toxicology"},{"issue":"11","key":"1100_CR26","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/pros.21331","volume":"71","author":"L Gan","year":"2011","unstructured":"Gan L, et al. Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38\/p53\/p21 signaling. Prostate. 2011;71(11):1158\u201366.","journal-title":"Prostate"},{"issue":"6","key":"1100_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9(6):400\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"4, Supplement","key":"1100_CR28","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1067\/mai.2001.117819","volume":"108","author":"KC Zimmermann","year":"2001","unstructured":"Zimmermann KC, Green DR. How cells die: apoptosis pathways. J Allergy Clin Immunol. 2001;108(4, Supplement):S99\u2013103.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1100_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1210\/endo.136.2.7530653","volume":"136","author":"C Lee","year":"1995","unstructured":"Lee C, et al. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology. 1995;136(2):796\u2013803.","journal-title":"Endocrinology"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-018-1100-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T16:30:16Z","timestamp":1603902616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-018-1100-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1007\/s12032-018-1100-0","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"40"}}